# Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae

> **NCT02961751** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 211 (actual)

## Conditions studied

- Gonococcal Infection

## Interventions

- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT02961751
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-19
- **Primary completion:** 2019-01-04
- **Final completion:** 2019-01-04
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02961751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02961751, "Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02961751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*